Growth Metrics

Merck (MRK) Net Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,391.00
Dec 31, 2025 -1,544.00
Sep 30, 2025 548.00
Jun 30, 2025 -473.00
Mar 31, 2025 878.00
Dec 31, 2024 499.00
Sep 30, 2024 -1,492.00
Jun 30, 2024 368.00
Mar 31, 2024 3,860.00
Dec 31, 2023 -3,814.00
Sep 30, 2023 6,925.00
Jun 30, 2023 -5,899.00
Jun 30, 2021 -120.00
Mar 31, 2021 -66.00
Dec 31, 2020 -87.00
Sep 30, 2020 -142.00
Jun 30, 2020 -1,963.00
Mar 31, 2020 7,027.00
Dec 31, 2019 -5,896.00
Sep 30, 2019 -710.00
Jun 30, 2019 -398.00
Mar 31, 2019 1,029.00
Dec 31, 2018 -197.00
Sep 30, 2018 174.00
Jun 30, 2018 901.00
Mar 31, 2018 1,733.00
Dec 31, 2017 -946.00
Sep 30, 2017 -2,014.00
Jun 30, 2017 315.00
Mar 31, 2017 2,230.00
Dec 31, 2016 -2,657.00
Sep 30, 2016 849.00
Jun 30, 2016 15.00
Mar 31, 2016 252.00
Dec 31, 2015 -856.00
Sep 30, 2015 1,115.00
Jun 30, 2015 -313.00
Mar 31, 2015 -5,974.00
Dec 31, 2014 6,193.00
Sep 30, 2014 -1,062.00
Jun 30, 2014 173.00
Mar 31, 2014 967.00
Dec 31, 2013 -322.00
Sep 30, 2013 193.00
Jun 30, 2013 -665.00
Mar 31, 2013 2,787.00
Dec 31, 2012 -2,808.00
Sep 30, 2012 56.00
Jun 30, 2012 -28.00
Mar 31, 2012 2,225.00
Dec 31, 2011 -2,152.00
Sep 30, 2011 -256.00
Jun 30, 2011 2,886.00
Mar 31, 2011 2,181.00
Dec 31, 2010 -1,503.00
Sep 30, 2010 -415.00
Jun 30, 2010 386.00
Mar 31, 2010 -12,763.00
Dec 31, 2009 10,131.00
Sep 30, 2009 -284.00
Jun 30, 2009 -418.00